Sousa Alejandro

MD  PhD (31-08-1961)
Phisician by Santiago de Compostela University (1978-84) with final grade of upstanding
Doctoral Thesis: Study of new markers in prostate cancer. Grade: Cum Laude (1996). University of Santiago de Compostela. Coruña. Spain
Specialitsy training: Urologist. Juan Canalejo Hospital of la Coruña (1985-1991)
Working Experience: Urologist. Chief of section. Comarcal Hospital of Monforte (1991-Now)
Author or coauthor of more than 10 chapters in different books about urology field
Author or coauthor of more tan 50 publications on indexed magazines of the speciality in 5 different languages.
Author or coauthor of more tham 150 comunications in national or international congresses of the speciality in oral, poster or video formats
Coauthor of 2 patents of devices used in the treatment of urologic pathologies.
Live surgeries on national and international congresses (Iran, Argentina, Venezuela and Spain). Moreover, clinical formation courses including surgery on different hospitals of Spain and other countries (Germany, Greece, Italy, UK, Portugal, México, Iran)
Author of a new surgical thechnique and device for the treatment of male urinary incontinence (MRS-II) in 2001 which is being using actually in more than 25 countries.
Coauthor of a system of intravesical Chemohyperthermia for the treatament of non muscle invasive bladder cáncer by fluid recirculation which is being used in Spain, UK, Germany, Netherlands, Iran and Belgium
I have participated in many research clinical studies, as main or associated investigator, during the last 20 years
Belonging to five  national and international urological societies
Reviewer of 3 indexed magazines of urology (Actas Españolas de Urología, Archivos españoles de urología and European Journal of Oncology)
Work as a voluntary assitant urologist with a NGO in Santa Cruz de la Sierra, Bolivia
Legal expert on urology from 1996
All the related information is totally true and may proved with documents in case of need

Specific Curriculum Vitae on Chemohyperthermia

  • Sousa A, Piñeiro I, Uribarri C. Neoadjuvant Chemohyperthermia for the Treatment of High Risk Non Muscle Invasive Bladder Cancer (NMIBC): A Phase I Study.  Urology, 78 (3 suppl) Pages S67 2011.
  • Sousa A, Inman BA, Piñeiro I, et al. A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer. Int J Hyperthermia 30(3):166-70. 2014
  • Sousa A, Piñeiro I, Aparici V et al. Budgetary impact analysis of the treatment of medium-high risk NMIBC using neoadjuvant chemohyperthermia compared to standard adjuvant treatment with BCG. Arch Esp Urol In press 2015
Colaboration to Congresses and Courses
  • Sousa A, Piñeiro I, Uribarri C. Neoadjuvant Chemohyperthermia for the Treatment of High Risk Non Muscle Invasive Bladder Cancer (NMIBC): A Phase I Study.  31st Congress of the Société Internationale d'Urologie. 15-16 October Berlin. Germany (SIU 2011)
  • Sousa A, Piñeiro I, Aparici JV et al. Hish risk non muscle invasive bladder cáncer treated with neoadjuvant chemohyperthermia with Mytomicin C, Resultas after 19 months of follow up. 32st Congress of the Société Internationale d'Urologie. 30 September -  4 October. Fukuoka. Japan (SIU 2012)
  • Sousa A. Side effects of intravesical chemohyperthermia in bladder cancer. First 350 instilations  28th Annual Meeting of the European Society for Hyperthermic Oncology Munich, Germany June 19–22 (ESHO 2013)
  • Sousa A. Quimiohipertermia en el carcinoma urotelial no infiltrante. XVII congreso anual de la Asociación Urológica Navarro-Aragonesa 23-24 Mayo (AUNAR 2014)
  • Sousa A. Hyperthermia and intravesical treatments: Possibilities and clinical impact. I International course about Hot-Spots in Urology. November 27-28 Madrid (UROUP 2014)
  • Sousa A. Chemohyperthermia a new paradigma in NMIBC. 12º Asian Congress of Urology. December 5-9. Kish Island. Iran (ACU 2014)  
Assistance to courses about oncologic hyperthermia
ESHO School on Clinical hyperthermia, Huntsham Court, Devon, UK, 3rd -6th February 2014

  • Best communication to the XXII congreso de la Sociedad Gallega de Urología. May 11-12 Lugo. Spain 2012
    A. Sousa, I. Pineiro I, J.V. Aparici et al QuImiohipertermia (QHT) Neoadyuvante para el tratamiento de los tumores no músculo invasivos de riesgo medio -alto: Estudio en Fase I.
On going studies

HIVEC (Hyperthermic IntraVEsical Chemotherapy) for patients with intermediate risk NMIBC compared to standard intravesical instillation of chemotherapy as adjuvant treatment. A comparative, prospective, randomized study
Multicentric Study. Main investigators:
Palou J. Fundació Puigvert Barcelona Spain
Solsona E. IVO Valencia. Spain
Sousa A. Monforte de Lemos. Lugo. Spain
Start date: Jun 2014 Final date: Jun 2018

Chemo-resection with hyperthermic intravesical instillation (HIVEC-R) vs standard treatment in patients with NMIBC: Porspective, comparative, study and randomized trial of efficacy and tolerability.
Multicentric Study. Main investigator:
Sousa A. Monforte de Lemos. Lugo. Spain
Start date: Dec 2014 Final date: Dec 2018
Pending of aprovation (AMPS and CEIC)

Expression in normal Urothelium and bladder cancer of the Heat shock Proteins 27, 60, 70 and 90 in the cytoplasm and cell membrane after a treatment of quimiohipertemia with Mitomycin C to 43 ° C
Monocentric. Main investigator:
Sousa A. Monforte de Lemos. Lugo. Spain
Star Date: Jan 2015 Final Date Dec 2015
Pending of aprovation (AMPS and CEIC)


Membership of the Advisory Group of the Spanish Association of Urology which drew up recommendations to the Ministry of health regarding the lack of BCG for bladder cancer treatment non-muscle invasive of high grade. Meeting held at the headquarters of the AEU in Madrid on October 13, 2014
Full board: J Manuel Cozar (Virgen del camino Hospital - Granada), Joan Palou (Fundació Puigvert - Barcelona) Eduardo Solsona (Instituto Valenciano de Oncología - Valencia) Miguel Unda (Basurto Hospital - Bilbao), Bernardino Miñana (Morales Messeguer Hospital - Murcia) and Alejandro Sousa (Comarcal de Monforte Hospital - Lugo)
Elaboration of the “quick derivation ways” of the Comarcal Monforte Hospital for early diagnosis of bladder cancer. November 2014. Monforte: Lugo Spain

Alejandro Sousa Escandón MD. PhD.
Consulting Urologist